You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Respiratory Tract Neoplasms

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lung Cancer, Multiple Pulmonary Nodules, Lung Tumors Trial in Orlando, Rochester, Pinehurst (Ion Endoluminal System)

Not yet recruiting
  • Lung Cancer
  • +8 more
  • Ion Endoluminal System
  • Orlando, Florida
  • +2 more
Aug 16, 2023

NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in Worldwide (Furmonertinib)

Recruiting
  • Non-Small Cell Lung Cancer
  • +14 more
  • Glendale, California
  • +12 more
Feb 2, 2023

Lung Tumor Malignant, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-451)

Recruiting
  • Lung Neoplasm Malignant
  • +18 more
  • Fairfax, Virginia
    New Experimental Therapeutics of Virginia (NEXT Oncology)
Mar 29, 2022

Respiratory Tract Diseases, Tumors, Tumors by Histologic Type Trial run by the National Cancer Institute (NCI) (Bevacizumab)

Not yet recruiting
  • Respiratory Tract Diseases
  • +14 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Apr 10, 2023

Lung Tumor, NSCLC, Respiratory Tract Tumors Trial in United States (BLU-701, osimertinib, carboplatin)

Recruiting
  • Lung Neoplasm
  • +26 more
  • Boston, Massachusetts
  • +6 more
Jun 23, 2022

Tumors, Tumors, Glandular and Epithelial, Tumors by Histologic Type Trial in San Antonio (Entinostat, Placebo)

Completed
  • Neoplasms
  • +14 more
  • San Antonio, Texas
    The START Center for Cancer Care
Apr 21, 2022

Respiratory Tract Dysplasia or Lung Cancer, Head and Neck

Recruiting
  • Esophageal Cancer
  • +3 more
  • immunohistochemistry staining method
  • +3 more
  • Aurora, Colorado
    University of Colorado Cancer Center at UC Health Sciences Cente
Nov 1, 2022

Tumors, Tumors, Glandular and Epithelial, Tumors by Histologic Type Trial in San Antonio (Entinostat, Pembrolizumab)

Completed
  • Neoplasms
  • +13 more
  • San Antonio, Texas
    The START Center for Cancer Care
Jan 24, 2022

NSCLC, Lung Tumors, Respiratory Tract Tumors Trial in Australia, Canada (Low dose CT)

Active, not recruiting
  • Non-small Cell Lung Cancer
  • +8 more
  • Low dose CT
  • Sydney, New South Wales, Australia
  • +5 more
Jul 15, 2021

Biomarkers in Lung Cancer

Not yet recruiting
  • Lung Nodule
  • Lung Cancer
  • Extra blood sampling, Non-invasive or leftover samples or medical waste
  • Toulouse, France
    Larrey Hospital
Sep 19, 2023

NSCLC, NSCLC, Carcinoma, Bronchogenic Trial in United States (furmonertinib 240 mg, furmonertinib 160 mg, platinum-based chemo)

Recruiting
  • Non-Small Cell Lung Cancer
  • +13 more
  • furmonertinib 240 mg
  • +2 more
  • Yuma, Arizona
  • +37 more
Dec 14, 2022

Tumors, Colorectal Tumors, Melanoma Trial in United States (Alectinib)

Terminated
  • Neoplasms
  • +27 more
  • Culver City, California
  • +28 more
Jul 25, 2022

Pralsetinib to Best Available Therapy in RET-Fusion Positive

Enrolling by invitation
  • RET-fusion Non Small Cell Lung Cancer
  • +16 more
    • New York, New York
    • +2 more
    Aug 9, 2021

    Lung Tumors, NSCLC, Respiratory Tract Tumors Trial in Worldwide (BLU-945, osimertinib)

    Recruiting
    • Lung Neoplasms
    • +23 more
    • La Jolla, California
    • +35 more
    Oct 6, 2022

    Lung Tumors, Respiratory Tract Tumors Trial in Calgary, Edmonton (Computed Tomography, Active smokers - Smoking cessation arm,

    Active, not recruiting
    • Lung Neoplasms
    • Respiratory Tract Neoplasms
    • Computed Tomography
    • +2 more
    • Calgary, Alberta, Canada
    • +1 more
    Mar 4, 2021

    Sputum DNA Testing for Lung Cancer in China

    Recruiting
    • Lung Cancer
    • +15 more
    • Diagnostic Test: Sputum DNA methylation analysis
    • chest CT or pathological examination
    • Guangzhou, Guangdong, China
      Nanfang Hospital of Southern Medccal University
    Dec 29, 2022

    Respiratory Endoscopy: Diagnostic Yield, Technical Factors and

    Completed
    • Lung Neoplasm
    • +3 more
    • Respiratory endoscopy
    • Singapore, Singapore
      Singapore General Hospital
    Sep 29, 2021

    RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

    Active, not recruiting
    • RET-altered Non Small Cell Lung Cancer
    • +39 more
    • pralsetinib (BLU-667)
    • Phoenix, Arizona
    • +65 more
    Nov 10, 2022

    Advanced Malignant Tumor, Castleman Disease, Digestive System Carcinoma Trial in Houston (biological, other, drug)

    Active, not recruiting
    • Advanced Malignant Neoplasm
    • +38 more
    • Bevacizumab
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 18, 2022

    Respiratory System Disease, COPD, Asthma Copd Trial in Chuncheon, Seoul (Conventional rehabilition treatment(e.g leaflet)

    Recruiting
    • Respiratory System Disease
    • +9 more
    • Conventional rehabilition treatment(e.g leaflet) educated by hospital
    • Digital treatment based on Respiratory Rehabilitation Software
    • Chuncheon, Korea, Republic of
    • +2 more
    Mar 18, 2022

    Malignant Tumor of Bone and Articular Cartilage, Malignant Tumors of Female Genital Organs, Malignant Tumors of Independent

    Recruiting
    • Malignant Neoplasm of Bone and Articular Cartilage
    • +9 more
    • Houston, Texas
      The University of Texas MD Anderson Cancer Center
    Oct 26, 2022

    Respiratory Tract Infections Trial in Odense C (POC PCR-test device)

    Recruiting
    • Respiratory Tract Infections
    • POC PCR-test device
    • Odense C, Denmark
      Research Unit of General Practice, Dept. of Public Health, Unive
    Nov 1, 2023

    Thoracic Diseases, Respiratory Tract Diseases, Cancer of Lung Trial in Rochester (Skin Biopsy)

    Active, not recruiting
    • Thoracic Diseases
    • +13 more
    • Skin Biopsy
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Sep 13, 2021

    Viral Upper Respiratory Tract Infection Trial (recombinant human interferon ? spray)

    Not yet recruiting
    • Viral Upper Respiratory Tract Infection
    • recombinant human interferon ω spray
    • (no location specified)
    May 7, 2023

    Upper Respiratory Tract Infection Bacterial Trial in Sopot (AP203 mixture (RESCOVIN®), Placebo)

    Completed
    • Upper Respiratory Tract Infection Bacterial
    • AP203 mixture (RESCOVIN®)
    • Placebo
    • Sopot, Poland
      Pomorskie Centrum Reumatologiczne im. dr Jadwigi Titz-Kosko
    Sep 7, 2023